Medicago, which makes influenza vaccines, is now working on a SARS-CoV-2 vaccine. Medicago scientists essentially clone viruses by injecting genetic material into Nicotiana benthamiana plants, which then produce virus-like particles that can be used for vaccines, says senior director Natalie Charland, and at least one candidate has shown promise in mice.
Company uses plant to manufacture coronavirus vaccine
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.